ROG — Roche Holding AG Balance Sheet
0.000.00%
- CH₣208.63bn
- CH₣232.06bn
- CH₣60.50bn
- 88
- 35
- 84
- 83
Annual balance sheet for Roche Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12,334 | 13,031 | 9,767 | 10,510 | 17,317 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 11,740 | 12,651 | 13,866 | 12,980 | 13,485 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 32,942 | 35,627 | 33,816 | 33,446 | 40,036 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 23,270 | 24,412 | 24,208 | 22,939 | 23,740 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 86,138 | 92,317 | 88,151 | 90,468 | 101,801 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 25,401 | 38,416 | 27,239 | 24,824 | 27,023 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 49,797 | 67,828 | 60,159 | 61,153 | 70,034 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 36,341 | 24,489 | 27,992 | 29,315 | 31,767 |
Total Liabilities & Shareholders' Equity | 86,138 | 92,317 | 88,151 | 90,468 | 101,801 |
Total Common Shares Outstanding |